These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 35798843)

  • 1. A p53-phosphoinositide signalosome regulates nuclear AKT activation.
    Chen M; Choi S; Wen T; Chen C; Thapa N; Lee JH; Cryns VL; Anderson RA
    Nat Cell Biol; 2022 Jul; 24(7):1099-1113. PubMed ID: 35798843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of PI3K effector signalling in cancer by the phosphoinositide phosphatases.
    Rodgers SJ; Ferguson DT; Mitchell CA; Ooms LM
    Biosci Rep; 2017 Feb; 37(1):. PubMed ID: 28082369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endomembrane PtdIns(3,4,5)P3 activates the PI3K-Akt pathway.
    Jethwa N; Chung GH; Lete MG; Alonso A; Byrne RD; Calleja V; Larijani B
    J Cell Sci; 2015 Sep; 128(18):3456-65. PubMed ID: 26240177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The INPP4B paradox: Like PTEN, but different.
    Hamila SA; Ooms LM; Rodgers SJ; Mitchell CA
    Adv Biol Regul; 2021 Dec; 82():100817. PubMed ID: 34216856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PI3K/Akt-mediated regulation of p53 in cancer.
    Abraham AG; O'Neill E
    Biochem Soc Trans; 2014 Aug; 42(4):798-803. PubMed ID: 25109960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The non-canonical nuclear functions of key players of the PI3K-AKT-MTOR pathway.
    Gupta S; Kumar M; Chaudhuri S; Kumar A
    J Cell Physiol; 2022 Aug; 237(8):3181-3204. PubMed ID: 35616326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuclear phosphatidylinositol 3,4,5-trisphosphate, phosphatidylinositol 3-kinase, Akt, and PTen: emerging key regulators of anti-apoptotic signaling and carcinogenesis.
    Martelli AM; Cocco L; Capitani S; Miscia S; Papa S; Manzoli FA
    Eur J Histochem; 2007; 51 Suppl 1():125-31. PubMed ID: 17703603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Could changes in the regulation of the PI3K/PKB/Akt signaling pathway and cell cycle be involved in astrocytic tumor pathogenesis and progression?
    Hlobilkova A; Ehrmann J; Sedlakova E; Krejci V; Knizetova P; Fiuraskova M; Kala M; Kalita O; Kolar Z
    Neoplasma; 2007; 54(4):334-41. PubMed ID: 17822324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Avian Reovirus Protein p17 Functions as a Nucleoporin Tpr Suppressor Leading to Activation of p53, p21 and PTEN and Inactivation of PI3K/AKT/mTOR and ERK Signaling Pathways.
    Huang WR; Chiu HC; Liao TL; Chuang KP; Shih WL; Liu HJ
    PLoS One; 2015; 10(8):e0133699. PubMed ID: 26244501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ZEB1 serves as an oncogene in acute myeloid leukaemia via regulating the PTEN/PI3K/AKT signalling pathway by combining with P53.
    Li L; Feng Y; Hu S; Du Y; Xu X; Zhang M; Peng X; Chen F
    J Cell Mol Med; 2021 Jun; 25(11):5295-5304. PubMed ID: 33960640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apoptosis-induced effects of extract from Artemisia annua Linné by modulating PTEN/p53/PDK1/Akt/ signal pathways through PTEN/p53-independent manner in HCT116 colon cancer cells.
    Kim EJ; Kim GT; Kim BM; Lim EG; Kim SY; Kim YM
    BMC Complement Altern Med; 2017 Apr; 17(1):236. PubMed ID: 28454566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DRAM1 regulates autophagy and cell proliferation via inhibition of the phosphoinositide 3-kinase-Akt-mTOR-ribosomal protein S6 pathway.
    Lu T; Zhu Z; Wu J; She H; Han R; Xu H; Qin ZH
    Cell Commun Signal; 2019 Mar; 17(1):28. PubMed ID: 30902093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AKT induces senescence in human cells via mTORC1 and p53 in the absence of DNA damage: implications for targeting mTOR during malignancy.
    Astle MV; Hannan KM; Ng PY; Lee RS; George AJ; Hsu AK; Haupt Y; Hannan RD; Pearson RB
    Oncogene; 2012 Apr; 31(15):1949-62. PubMed ID: 21909130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chlamydia trachomatis plasmid-encoded protein Pgp3 inhibits apoptosis via the PI3K-AKT-mediated MDM2-p53 axis.
    Zou Y; Lei W; Su S; Bu J; Zhu S; Huang Q; Li Z
    Mol Cell Biochem; 2019 Feb; 452(1-2):167-176. PubMed ID: 30132214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Akt is efficiently activated by PIF-pocket- and PtdIns(3,4,5)P3-dependent mechanisms leading to resistance to PDK1 inhibitors.
    Najafov A; Shpiro N; Alessi DR
    Biochem J; 2012 Dec; 448(2):285-95. PubMed ID: 23030823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Galangin Induces p53-independent S-phase Arrest and Apoptosis in Human Nasopharyngeal Carcinoma Cells Through Inhibiting PI3K-AKT Signaling Pathway.
    Lee CC; Lin ML; Meng M; Chen SS
    Anticancer Res; 2018 Mar; 38(3):1377-1389. PubMed ID: 29491062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melatonin treatment improves human umbilical cord mesenchymal stem cell therapy in a mouse model of type II diabetes mellitus via the PI3K/AKT signaling pathway.
    Aierken A; Li B; Liu P; Cheng X; Kou Z; Tan N; Zhang M; Yu S; Shen Q; Du X; Enkhbaatar BB; Zhang J; Zhang R; Wu X; Wang R; He X; Li N; Peng S; Jia W; Wang C; Hua J
    Stem Cell Res Ther; 2022 Apr; 13(1):164. PubMed ID: 35414044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fine-tuning the intensity of the PKB/Akt signal enables diverse physiological responses.
    Zhou X; Cordon-Barris L; Zurashvili T; Bayascas JR
    Cell Cycle; 2014; 13(20):3164-8. PubMed ID: 25485494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated expression of p53 gain-of-function mutation R175H in endometrial cancer cells can increase the invasive phenotypes by activation of the EGFR/PI3K/AKT pathway.
    Dong P; Xu Z; Jia N; Li D; Feng Y
    Mol Cancer; 2009 Nov; 8():103. PubMed ID: 19917135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of miR-122-5p regulating the activation of PI3K-Akt-mTOR signaling pathway on the cell proliferation and apoptosis of osteosarcoma cells through targeting TP53 gene.
    Li KW; Wang SH; Wei X; Hou YZ; Li ZH
    Eur Rev Med Pharmacol Sci; 2020 Dec; 24(24):12655-12666. PubMed ID: 33378012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.